Inventor · disambiguated record
Eugene R. Wagner
Also filed as: MATTHEWS DONALD P · MCDERMOTT ROGER D · RENZI ALFRED A · WAGNER EUGENE R
24 granted patents·426 citations·filing 1974–1988
95Inventor score
Top patents by PatentIndex Score
24 records- 0196US4076841AHypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamidesDOW CHEMICAL CO·Filed 1977·Granted Feb 28, 1978·65 cites·10 claims
- 0296US4029812ANovel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamidesDOW CHEMICAL CO·Filed 1976·Granted Jun 14, 1977·72 cites·7 claims
- 0395US4078084ANovel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamidesDOW CHEMICAL CO·Filed 1977·Granted Mar 7, 1978·53 cites·7 claims
- 0491US4584379AIsoquinoline thromboxane synthetase inhibitorsMERRELL DOW PHARMA·Filed 1985·Granted Apr 22, 1986·36 cites·4 claims
- 0589US4248389AContainer sorting and handling systemTHOMPSON FREMONT G·Filed 1979·Granted Feb 3, 1981·154 cites·6 claims
- 0671US4012523AHypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-(thio or sulfonyl) alkanoic acids and derivativesDOW CHEMICAL CO·Filed 1974·Granted Mar 15, 1977·8 cites·62 claims
- 0762US4218475AHypolipidemic benzylaminobenzene alkanoic or alkenoic acidsDOW CHEMICAL CO·Filed 1978·Granted Aug 19, 1980·4 cites·7 claims
- 0851US4067998A2-((3,5-Di-tert-butylphenyl)thio) alkanoic acids and derivativesDOW CHEMICAL CO·Filed 1975·Granted Jan 10, 1978·8 cites·35 claims
- 0950US4143151AMethod for treating hyperglycemia in mammals using arylamino benzoic acidsDOW CHEMICAL CO·Filed 1978·Granted Mar 6, 1979·8 cites·6 claims
- 1049US4062975AAmino substituted arylthio-alkanoic acids having hypolipidemic activityDOW CHEMICAL CO·Filed 1976·Granted Dec 13, 1977·2 cites·10 claims
- 1146US4105791AHypolipidemic cycloalkylaminobenzoic acidsDOW CHEMICAL CO·Filed 1976·Granted Aug 8, 1978·2 cites·30 claims
- 1243US4788335AHypoglycemic N-(2-substituted-3-dialkylamino-2-propenylidene)-N-alkylalkanaminium saltsMERRELL DOW PHARMA·Filed 1987·Granted Nov 29, 1988·4 cites·4 claims
- 1343US4192884ASubstituted 4-(((thienyl)methyl)-amino)benzoic acids and a method for treating hypolipidemiaDOW CHEMICAL CO·Filed 1978·Granted Mar 11, 1980·1 cites·27 claims
- 1435US4857663AHypoglycemic N-(2-substituted-3-dialkylamino-2-propenylidene)-N-alkylalkanaminium saltsMERRELL DOW PHARMA·Filed 1988·Granted Aug 15, 1989·3 cites·2 claims
- 1535US4133890AHypolipidemic compositions and method employing derivatives of 4-(((1,3-benzodioxol-5-yl)methyl)amino)benzoic acidDOW CHEMICAL CO·Filed 1977·Granted Jan 9, 1979·2 cites·15 claims
- 1634US4286090ANovel tetrazolo [4,5-C][1,2,3]benzotriazinesDOW CHEMICAL CO·Filed 1980·Granted Aug 25, 1981·1 cites·4 claims
- 1734US4181737A4-((3-Methoxyphenyl)amino)benzoic acid, a method for treating hyperlipidemia, and compositions thereofDOW CHEMICAL CO·Filed 1978·Granted Jan 1, 1980·1 cites·3 claims
- 1833US4207330AMethod for treating hyperglycemia in mammals using arylamino benzoic acidsDOW CHEMICAL CO·Filed 1979·Granted Jun 10, 1980·1 cites·1 claims
- 1933US4103027AAmino substituted arylthio-alkanoic acids having hypolipidemic activityDOW CHEMICAL CO·Filed 1977·Granted Jul 25, 1978·0 cites·4 claims
- 2032US4103029AAmino substituted arylthio-alkanoic acids having hypolipidemic activityDOW CHEMICAL CO·Filed 1977·Granted Jul 25, 1978·0 cites·4 claims
- 2131US4263320AHypoglycemic phenylpropynylamino benzoic acidsDOW CHEMICAL CO·Filed 1979·Granted Apr 21, 1981·0 cites·19 claims
- 2230US4533677AHypoglycemic N-(2-substituted-3-Dialkylamino-2-propenylidene)-N-alkylalkanaminium saltsMERRELL DOW PHARMA·Filed 1983·Granted Aug 6, 1985·1 cites·9 claims
- 2330US4178385AMethod for treating hyperlipidemia in primates using 4-((4-fluorophenylmethyl)amino)benzoic acidDOW CHEMICAL CO·Filed 1978·Granted Dec 11, 1979·0 cites·5 claims
- 2429US4206223AMethod for treating hyperglycemia in mammals using 4-(((1,3-benzodioxol-5-yl)methyl)amino)benzoic acid or derivatives thereofDOW CHEMICAL CO·Filed 1979·Granted Jun 3, 1980·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Eugene R. Wagner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →